[논문]Dementia

Cunningham, EL; McGuinness, B; Herron, B; Passmore, AP

Dementia 원문보기

Ulster medical journal, v.84 no.2, 2015년, pp.79 - 87

Cunningham, EL (Centre for Public Health, Queen's University Belfast) , McGuinness, B (Centre for Public Health, Queen's University Belfast) , Herron, B (Belfast Health and Social Care Trust) , Passmore, AP (Centre for Public Health, Queen's University Belfast)

Abstract ▼ AI-Helper

Dementia is a clinical diagnosis requiring new functional dependence on the basis of progressive cognitive decline. It is estimated that 1.3% of the entire UK population, or 7.1% of those aged 65 or over, have dementia. Applying these to 2013 population estimates gives an estimated number of 19,765 people living with dementia in Northern Ireland. The clinical syndrome of dementia can be due to a variety of underlying pathophysiological processes. The most common of these is Alzheimer's disease (50-75%) followed by vascular dementia (20%), dementia with Lewy bodies (5%) and frontotemporal lobar dementia (5%). The clinical symptoms and pathophysiological processes of these diseases overlap significantly. Biomarkers to aid diagnosis and prognosis are emerging. Acetylcholinesterase inhibitors and memantine are the only medications currently licensed for the treatment of dementia. The nature of symptoms mean people with dementia are more dependent and vulnerable, both socially and in terms of physical and mental health, presenting evolving challenges to society and to our healthcare systems.

참고문헌 (54)

1 Knapp M Prince M Dementia UK: full report 2007 London Alzheimer's Society
2 Prince M Knapp M Guerchet M McCrone P Prina M Comas-Herrera A Dementia UK: Update 2014 London Alzheimer's Society
3 Matthews FE Arthur A Barnes LE Bond J Jagger C Robinson L A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II Lancet. 2013 382 9902 1405 12 23871492
4 Prince M Guerchet M Prina M Policy Brief for Heads of Government: The Global Impact of Dementia 2013 - 2050 2013 London Alzheimer's Disease International
5 Todd S Barr S Roberts M Passmore AP Survival in dementia and predictors of mortality: a review Int J Geriatr Psychiatry. 2013 28 11 1109 24 23526458

상세보기
6 Prince M Jackson J World Alzheimer Report 2009 2009 London Alzheimer's Disease International
7 McKhann GM Knopman DS Chertkow H Hyman BT Jack CR Jr Kawas CH The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Demen. 2011 7 3 263 9
8 McKeith IG Dickson DW Lowe J Emre M O'Brien JT Feldman H Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium Neurology. 2005 65 12 1863 72 16237129

상세보기
9 Rascovsky K Hodges JR Knopman D Mendez MF Kramer JH Neuhaus J Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia Brain. 2011 134 Pt 9 2456 77 21810890
10 Gorno-Tempini ML Hillis AE Weintraub S Kertesz A Mendez M Cappa SF Classification of primary progressive aphasia and its variants Neurology. 2011 76 11 1006 14 21325651

상세보기
11 Gorelick PB Scuteri AC Black SE DeCarli C Greenberg SM Iadecola C Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke. 2011 42 9 2672 13 21778438

상세보기
12 Petersen RC MJ Mild cognitive impairment as a clinical entity and treatment target Arch Neurol. 2005 62 7 1160 3 16009779

상세보기
13 Albert MS DeKosky ST Dickson D Dubois B Feldman HH Fox NC The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Demen. 2011 7 3 270 9
14 Mitchell AJ Shiri-Feshki M Rate of progression of mild cognitive impairment to dementia – meta-analysis of 41 robust inception cohort studies Acta Psychiatr Scand. 2009 119 4 252 65 19236314

상세보기
15 Dubois B Feldman HH Jacova C Hampel H Molinuevo JL Blennow K Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria Lancet Neurology. 2014 13 6 614 29

상세보기
16 Hachinski VC Iliff LD Zilhka E Du Boulay GH McAllister VL Marshall J Cerebral blood flow in dementia Arch Neurol. 1975 32 9 632 7 1164215

상세보기
17 Roman GC Tatemichi TK Erkinjuntti T Cummings JL Masdeu JC Garcia JH Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop Neurology. 1993 43 2 250 60 8094895

상세보기
18 DSM-5 Task Force Diagnostic and statistical manual of mental disorders 2013 5th ed Washington, DC American Psychiatric Association
19 Folstein MF Folstein SE McHugh PR “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res. 1975 12 3 189 98 1202204

상세보기
20 Wharton SB Brayne C Savva GM Matthews FE Forster G Simpson J Epidemiological neuropathology: the MRC Cognitive Function and Aging Study experience J Alzheimers Dis. 2011 25 2 359 72 21422529
21 Frisoni GB Jack CR Jr Bocchetta M Bauer C Frederiksen KS Liu Y The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity Alzheimers Dement. 2015 11 2 111 25 25267715
22 Chouraki V Seshadri S Genetics of Alzheimer's Disease Adv Genet. 2014 87 245 94 25311924

상세보기
23 Verghese PB Castellano J Holtzman DM Apolipoprotein E in Alzheimer's Disease and other neurological disorders Lancet Neurology. 2011 10 3 241 52

상세보기
24 Guerreiro R Wojtas A Bras J Carrasquillo M Rogaeva E Majounie E TREM2 Variants in Alzheimer's Disease N Engl J Med. 2013 368 2 117 27 23150934

상세보기
25 Jonsson T Stefansson H Steinberg S Jonsdottir I Jonsson PV Snaedal J Variant of TREM2 Associated with the risk of Alzheimer's disease N Engl J Med. 2013 368 2 107 16 23150908

상세보기
26 Lambert J Ibrahim-Verbaas CA Harold D Naj AC Sims R Bellenguez C Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease Nat Genet. 2013 45 12 1452 8 24162737

상세보기
27 Beecham GW Hamilton K Naj AC Martin ER Huentelman M Myers AJ Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias PLoS Genetics. 2014 10 9 e1004606 25188341

상세보기
28 Ferencz B Gerritsen L Genetics and Underlying Pathology of Dementia Neuropsychol Rev. 2015 25 1 113 24 25567624

상세보기
29 Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 2001 69 3 89 95 11240971

상세보기
30 Vos SJ Verhey F Frölich L Kornhuber J Wiltfang J Maier W Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage Brain 2015 2 17 Epub ahead of print 10.1093/brain/awv029

상세보기
31 Jack CR Jr Wiste HJ Weigand SD Rocca WA Knopman DS Mielke MM Age-specific population frequencies of cerebral beta-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study Lancet Neurol. 2014 13 10 997 1005 25201514
32 Carrillo MC Blennow K Soares H Lewczuk P Mattsson N Oberoi P Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: an update from the Alzheimer's Association Global Biomarkers Consortium Alzheimers Dement. 2013 9 2 137 40 23274154
33 Klunk WE Koeppe RA Price JC Benzinger TL Devous MD Sr Jagust WJ The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET Alzheimers Dement. 2015 11 1 1 15 25443857
34 Bocchetta M Galluzzi S Kehoe PG Aguera E Bernabei R Bullock R The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey Alzheimers Dement. 2015 11 2 195 206 25150733
35 National Collaborating Centre for Mental Health Leicester: The British Psychological Society and Gaskell Dementia: The NICE–SCIE Guideline on supporting people with dementia and their carers in health and social care. National Clinical Practice Guideline; 42 2007
36 McCleery J Morgan S Bradley K Noel-Storr A Ansorge O Hyde C Cochrane Database of Systematic Reviews Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies 2015 1 010633
37 Deckers K van Boxtel MP Schiepers OJ de Vugt M Muñoz Sánchez JL Anstey KJ Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies Int J Geriatr Psychiatry. 2015 30 3 234 46 25504093

상세보기
38 Lakey L Counting the cost: Caring for people with dementia on hospital wards London Alzheimer's Society
39 Inouye SK Westendorp RG Saczynski JS Delirium in elderly people Lancet. 2014 383 9920 911 22 23992774
40 Gray SL Anderson ML Dublin S Hanlon JT Hubbard R Walker R Cumulative use of strong anticholinergics and incident dementia: A prospective cohort study JAMA Int Med. 2015 175 3 401 7
41 Billioti de Gage S Moride Y Ducruet T Kurth T Verdoux H Tournier M Benzodiazepine use and risk of Alzheimer's disease: casecontrol study BMJ 2014 9 9 349 Epub ahead of print 10.1136/BMJ.G5205

상세보기
42 Joint Formulary Committee British National Formulary (BNF) 69 2015 London BMJ Publishing Group and Royal Pharmaceutical Society
43 NICE Clinical Guideline; 42 Dementia: supporting people with dementia and their carers in health and social care. (Incorporating NICE technology appraisal guidance 217; 2011) .
44 London: National Institute for Health and Care Excellence; 2013
45 Birks J Cochrane Database of Systematic Reviews Cholinesterase inhibitors for Alzheimer's disease 2006 1 005593
46 McShane R Areosa Sastre A Minakaran N Cochrane Database of Systematic Reviews Memantine for dementia 2006 2 003154
47 Li Y Hai S Zhou Y Dong B Cholinesterase inhibitors for rarer dementias associated with neurological conditions Cochrane Database of Systematic Reviews 2015 3 009444

상세보기
48 Boxer AL Knopman DS Kaufer DI Grossman M Onyike C Graf- Radford N Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebocontrolled trial Lancet Neurol. 2013 12 2 149 56 23290598

상세보기
49 Howard R McShane R Lindesay J Ritchie C Baldwin A Barber R Donepezil and Memantine for moderate-to-severe Alzheimer's disease N Engl J Med. 2012 366 10 893 903 22397651

상세보기
50 Ritchie C Bajwa J Coleman G Hope K Jones R Lawton M Souvenaid ® : a new approach to management of early Alzheimer's disease J Nutr Health Aging. 2014 18 3 291 9 24626757
51 Ballard C Waite J Birks J Atypical antipsychotics for aggression and psychosis in Alzheimer's disease Cochrane Database of Systematic Reviews 2006 1 003476
52 Corbett A Pickett J Burns A Corcoran J Dunnett SB Edison P Drug repositioning for Alzheimer's disease Nature Rev.Drug Discov. 2012 11 11 833 46 23123941
53 Cummings JL Mega M Gray K Rosenberg-Thompson S Carusi DA Gornbein J The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia Neurology. 1994 44 12 2308 14 7991117

상세보기
54 Yesavage JA Sheikh JI Geriatric Depression Scale (GDS) Clin Gerontol. 1986 5 1-2 165 73

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Dementia 원문보기

Abstract ▼ AI-Helper

참고문헌 (54)

이 논문을 인용한 문헌

관련 콘텐츠

원문 보기

원문 URL 링크

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트